Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Panel: Benefits Unproven For BTG Emphysema Treatment

Jun 16 2018

• By Elizabeth Orr

FDA Advisory Committee Feature image

Related Content

US FDA Encourages Close Look At Safety Of Emphysema Device

Jun 13 2018

Market Intel: Promising Data At ATS2018 Inflate Hopes For Endobronchial Valves And New Device-Based COPD Therapies

Jun 15 2018

Related Companies

BTG plc

Additional Topics

Advisory Committees FDA Commercial Respiratory Medical Device

More from Respiratory

More from Device Area

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window